leisure time -WSS

leisure time

author：entertainment 2025-09-27 23:00:15 - browse：649

Biotech startup Generate Biomedicines, which uses artificial intelligence to find new drugs, raised $273 million in a Series C funding round from investors including pharma company Amgen and the VC arm of AI giant NVIDIA.

Generate was founded in 2018 by venture-creation firm Flagship Pioneering to use machine learning algorithms to identify antibodies, peptides, cell therapies, and other medicines. It launched its first clinical trial in July for a Covid monoclonal antibody, and is working on starting another clinical trial for an asthma treatment.

The biotech, which is based in Somerville, Mass., has big plans for the next couple of years: It has another 15 drug candidates in the works and plans to introduce 10 more annually, CEO Mike Nally told STAT.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Novavax promises a turnaround & Lilly roils the obesity market
Next article： 340B reform proposal comes out of Senate working group

WSS

Vyjuvek, a gene therapy for skin wounds, restored vision in one boy

Cano Health’s bankruptcy is a warning for Medicare Advantage

Medicare Advantage today, explained in one chart

New brain studies show LSD's effects on the brain in full color

eGenesis tests gene

Elizabeth Holmes banned from government health programs

focus

leisure time

focus

Medical records are filled with copy

The Biogen Aduhelm mess could happen again

As demand for Covid shots wanes, Moderna seeks its next success

Top private equity targets in 2023: cardiology, clinical trials, lasers

Apple is now the first public company to be valued at $3 trillion

Readout Newsletter: Amgen, Regeneron, BGI Group and more

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Medicare Advantage plans can’t deny care with AI, CMS warns

Medical records are filled with copy

Texas Medical Board asked to define abortion emergency exception

entertainment

Gene therapy for Afghan refugees’ infant will be fully covered

Copay coupons to count toward deductibles, after Biden court move

The Biogen Aduhelm mess could happen again

Elizabeth Holmes banned from government health programs

The Biogen Aduhelm mess could happen again

Parkinson’s finding may lead to tests and, someday, treatments

hotspot

focus

knowledge

explore